APA (7th ed.) Citation

Garcia, J., Dehner, C., Teoh, J., & Wallis, W. (2024). A Phase 1, Multicenter, Open-Label Study of UB-VV111 in Combination with Rapamycin in Relapsed/Refractory CD19+ B-Cell Malignancies. Blood, 144(Supplement 1), 1750.1. https://doi.org/10.1182/blood-2024-208461

Chicago Style (17th ed.) Citation

Garcia, Jacob, Christine Dehner, Jeffrey Teoh, and Wayne Wallis. "A Phase 1, Multicenter, Open-Label Study of UB-VV111 in Combination with Rapamycin in Relapsed/Refractory CD19+ B-Cell Malignancies." Blood 144, no. Supplement 1 (2024): 1750.1. https://doi.org/10.1182/blood-2024-208461.

MLA (9th ed.) Citation

Garcia, Jacob, et al. "A Phase 1, Multicenter, Open-Label Study of UB-VV111 in Combination with Rapamycin in Relapsed/Refractory CD19+ B-Cell Malignancies." Blood, vol. 144, no. Supplement 1, 2024, p. 1750.1, https://doi.org/10.1182/blood-2024-208461.